Why Aditxt (ADTX) Stock Is Skyrocketing

Aditxt Inc ADTX shares are trading higher by 96.5% to $8.58 during Tuesday’s session after the company announced it submitted an application for four new federal funding opportunities.

What To Know: Aditxt shares are trading higher after its subsidiary, Adivir, and its acquisition target, Appili Therapeutics, announced applications for up to $117.5 million in U.S. federal funding.

The funding aims to support the development of critical infectious disease treatments, including antifungal therapies and broad-spectrum antivirals, strengthening Aditxt's position in medical countermeasures.

Successful funding could advance key drug candidates through early-stage clinical trials. Appili, which has already secured $33.2 million in prior government funding, also reaffirmed its partnership with the U.S. Air Force Academy for its ATI-1701 biodefense vaccine.

Additionally, Aditxt's pending acquisition of Appili is nearing completion, with a March 31 deadline.

Read Also: Apple iPhone Shipments In China Drop 21% In January, Goldman Sachs Remains Bullish

How To Buy ADTX Stock

By now you're likely curious about how to participate in the market for Aditxt – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy “fractional shares,” which allows you to own portions of stock without buying an entire share.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to “go short” a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

According to data from Benzinga Pro, ADTX has a 52-week high of $54,500 and a 52-week low of $5.00.